FDCDDQ
RPRX icon

Federation des caisses Desjardins du Quebec’s Royalty Pharma RPRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$868K Buy
18,102
+4,630
+34% +$203K ﹤0.01% 1043
2025
Q4 		$521K Buy
13,472
+949
+8% +$36.2K ﹤0.01% 1272
2025
Q3 		$442K Buy
12,523
+2,394
+24% +$86.7K ﹤0.01% 1280
2025
Q2 		$365K Sell
10,129
-67,302
-87% -$2.23M ﹤0.01% 1099
2025
Q1 		$2.41M Buy
77,431
+1,282
+2% +$40.6K 0.01% 559
2024
Q4 		$1.94M Sell
76,149
-32,397
-30% -$859K 0.01% 592
2024
Q3 		$3.07M Buy
108,546
+1,286
+1% +$35.6K 0.02% 456
2024
Q2 		$2.83M Sell
107,260
-3,893
-4% -$108K 0.02% 473
2024
Q1 		$3.13M Buy
111,153
+3,001
+3% +$88.5K 0.02% 414
2023
Q4 		$3.04M Hold
108,152
– – 0.03% 351
2023
Q3 		$2.94M Sell
108,152
-8,028
-7% -$238K 0.03% 342
2023
Q2 		$3.57M Sell
116,180
-76,935
-40% -$2.61M 0.04% 342
2023
Q1 		$6.96M Buy
+193,115
New +$7.16M 0.08% 204
2022
Q4 		– Sell
-149,992
Closed -$6.03M – 2535
2022
Q3 		$6.03M Buy
149,992
+444
+0.3% +$19K 0.07% 207
2022
Q2 		$6.29M Buy
149,548
+126,358
+545% +$5.18M 0.07% 210
2022
Q1 		$903K Buy
23,190
+21,491
+1,265% +$844K 0.01% 675
2021
Q4 		$67.7K Hold
1,699
– – ﹤0.01% 1508
2021
Q3 		$61.3K Buy
1,699
+394
+30% +$15.3K ﹤0.01% 1544
2021
Q2 		$53.4K Hold
1,305
– – ﹤0.01% 1592
2021
Q1 		$57K Hold
1,305
– – ﹤0.01% 1506
2020
Q4 		$65.3K Buy
+1,305
New +$55.4K ﹤0.01% 1410

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RPRX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Royalty Pharma (RPRX) stake by 34% in Q1 2026, buying an estimated $203K and bringing the position to 18,102 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

Federation des caisses Desjardins du Quebec first reported a position in RPRX in Q4 2020 and has held it in 21 quarters since. The position peaked at $6.96M in Q1 2023. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 18,102 shares of Royalty Pharma worth $868K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 4,630 Royalty Pharma shares in Q1 2026, an estimated $203K.
  • Royalty Pharma made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1043 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Royalty Pharma in Q4 2020 and has held it in 21 quarters since.
  • Federation des caisses Desjardins du Quebec's Royalty Pharma position peaked at $6.96M in Q1 2023.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.